XOMA has some of the most diverse phage display antibody libraries available:
Integrated display platforms yield development advantages:
XOMA’s multiple custom antibody phage library and inter-platform compatible vectors enable rapid transition from phage to yeast or mammalian antibody display. Development of proprietary bacterial strains, improved cell-based panning methods, and antibody optimization technologies (OptimX™) enhance the quality of our antibody pipeline. Our custom software package, including SeqAgent™ and XAbTracker™, allows rapid sequence analysis and hit-to-lead clone tracking. Permanent and transient expression systems enable expression and manufacturing optimization. XOMA’s complete antibody discovery package increases the quality and speed of therapeutic antibody discovery.